# A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

> **NCT02897726** · PHASE1 · COMPLETED · sponsor: **NVP Healthcare** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NVP-1402
- **DRUG:** NVP-1402R

## Key facts

- **NCT ID:** NCT02897726
- **Lead sponsor:** NVP Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2017-07-03
- **Final completion:** 2017-07-03
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02897726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02897726, "A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02897726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*